Emerging Modalities in Mitigation of Antimicrobial Resistance, 1st ed. 2022
Langue : Anglais
Coordonnateurs : Akhtar Nadeem, Singh Kumar Siddharth, Prerna , Goyal Dinesh
Antimicrobial resistance (AMR) is one of the deadliest threats to global public health. This book focuses on dynamics in the landscape of AMR while informing about the latest technologies and strategies to mitigate it. The menace of AMR in different niches, routes of penetration across various domains, socio-economic impact, and the need for a 'One Health' approach in mitigating AMR has been emphasized. Factors involved in AMR, underlying mechanisms, and pharmacometrics in developing antimicrobials are highlighted. Emphasis is given to emerging technologies that are sustainable, scalable, and applicable to the global community, such as big data analytics, bioactive agents, phage therapy, and nanotechnology. The book also explores current and alternative treatment strategies to combat AMR, emphasizing the use of nanoparticles to target pathogens and as a viable alternative to antibiotics.
1. Antimicrobials in livestock production and its cross-domain dynamics.- 2. Antibiotics and resistance in environment.- 3. Antimicrobials in agriculture and its implications in antimicrobial resistance.- 4. Modern diagnostic tools for rapid detection of multidrug resistance.- 5. The use of antimicrobials in agriculture and socio-economic considerations in a global world.- 6. Epidemiology of microbial infections.- 7. Socioeconomic impact of antimicrobial resistance and their integrated mitigation by One Health approach.- 8. Regulations in antimicrobial drug development: Challenges, and new incentives.- 9. New insights into and updates on antimicrobial agents.- 10. Polyphenols as emerging antimicrobial agents.- 11. Antimicrobial peptides and small molecules as antibiotics substitute.- 12. Molecular mechanisms of antimicrobial resistance in S. aureus biofilms.- 13. Antimicrobial resistance: Meaning and developing realization.- 14. Chemical diversity in fungi: strategies to mitigate antimicrobial resistance.- 15. Phage therapy as an alternative treatment in the fight against AMR: Real-world problems and possible futures.- 16. Omics and in-silico approaches in the surveillance and monitoring of antimicrobial resistance.- 17. Antimicrobial activity of bioactive compounds (Thymoquinone & Eugenol) and its nanoformulations therapeutic potential.- 18. Nanoparticles as a future alternative against multiple drug resistance.- 19. Nano-cargos boarded defensins to combat multi-drug resistance.- 20. Implementation of nano-vehicles to disguise and fight multi-drug resistance.- 21. Silver nanoparticles as potent multi-drug resistant in-corporants in biomedicine.- 22. Role of gold nanoparticles against bacterial multidrug resistance (MDR): An emerging therapeutic revolution.- 23. Carbon nanoparticles: A potential cost-effective approach to counter antimicrobial resistance.- 24. Antimicrobial interfaces as augmentative strategy against antimicrobial resistance.- 25. Nano-Strategies against rising antimicrobial resistance (AMR): Metallic nanoparticles as nano-weapon.
Nadeem Akhtar, PhD, Department of Animal Biosciences, University of Guelph, Ontario N1G 2W1, Canada. Email: nadeembiotech@gmail.com. Dr. Nadeem Akhtar, Ph.D., currently works at the University of Guelph, Canada as a Research Associate. His current research focuses on biotechnology in animal nutrition, where the main objective is to improve animals' health for a better and disease-free lifestyle. Before the Research Associate role, he has worked as a Post-doctoral Researcher in the Department of Chemical Engineering, University of Waterloo, Canada (2019-2020), and in the Department of Animal Biosciences, University of Guelph, Canada (2015-2019). Dr. Akhtar was awarded a Ph.D. from the Department of Biotechnology, Thapar University, India. He has qualified National Eligibility test (NET-2010) and Graduate Aptitude Test (GATE) in Life Sciences (2010) and Biotechnology (2011). His scientific contributions include more than 22 articles in peer-reviewed international journals, 10 book chapters, and a patent. He reviewed several research articles for reputed journals, including RSC Advances, Journal of Applied Microbiology, Scientific Reports, Poultry Science, and many more.
Dr. Kumar Siddharth Singh, Institute for Microbiology, Leibniz University, Hannover, 30419, Germany. Email: ksid21@gmail.com. Dr. Kumar Siddharth Singh is a trained biotechnologist interested in host-microbe interactions, protein science, molecular microbiology, and omics technologies. He has a Master's degree in Biotechnology from Thapar University, Patiala, India, and Bachelor's degree from Anugrah Narayan College, Patna, India. He obtained a Ph.D. in Animal Biotechnology from ICAR-National Dairy Research Institute, Karnal, India, and developed a potential nutraceutical of probiotic origin to protect against gastrointestinal infections. He is also trained in food safety and quality management, emphasizing regulatory standards relevant to th
Presents cutting-edge research and next gen technology through the lens of sustainable methods to combat AMR An ideal resource for students, researchers, and industry professionals Designed to inform and promote new research and technologies against the growing threat of resistance
Date de parution : 02-2023
Ouvrage de 577 p.
15.5x23.5 cm
Date de parution : 02-2022
Ouvrage de 577 p.
15.5x23.5 cm
Thèmes d’Emerging Modalities in Mitigation of Antimicrobial... :
© 2024 LAVOISIER S.A.S.
